CannTrust Holdings Inc
CannTrust Holdings Inc. produces and distributes medical and recreational cannabis in Canada. It sells dried cannabis and cannabis extracts to the medical patients. CannTrust Holdings Inc. was incorporated in 2015 and is based in Vaughan, Canada.
CannTrust Holdings Inc (CNTTQ) - Net Assets
Latest net assets as of March 2019: $190.18 Million USD
Based on the latest financial reports, CannTrust Holdings Inc (CNTTQ) has net assets worth $190.18 Million USD as of March 2019.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($224.53 Million) and total liabilities ($34.35 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $190.18 Million |
| % of Total Assets | 84.7% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 215.71 |
CannTrust Holdings Inc - Net Assets Trend (2014–2018)
This chart illustrates how CannTrust Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for CannTrust Holdings Inc (2014–2018)
The table below shows the annual net assets of CannTrust Holdings Inc from 2014 to 2018.
| Year | Net Assets | Change |
|---|---|---|
| 2018-12-31 | $174.03 Million | +145.56% |
| 2017-12-31 | $70.87 Million | +576.98% |
| 2016-12-31 | $10.47 Million | +206.68% |
| 2015-12-31 | $-9.81 Million | -35.91% |
| 2014-12-31 | $-7.22 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to CannTrust Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 4017926200.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2018)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $207.06 Million | 118.98% |
| Other Comprehensive Income | $20.11 Million | 11.55% |
| Total Equity | $174.03 Million | 100.00% |
CannTrust Holdings Inc Competitors by Market Cap
The table below lists competitors of CannTrust Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
HDFC Bank of Sri Lanka
CM:HDFCN0000
|
$1.41K |
|
Sorento Capital Berhad
KLSE:0326
|
$1.42K |
|
Miss Grand International PCL
BK:MGI
|
$1.42K |
|
OUT
WAR:OUT
|
$1.42K |
|
Arab Cotton Ginning
EGX:ACGC
|
$1.41K |
|
Galileo Tech Ltd
TA:GLTC
|
$1.41K |
|
Zinc Media Group
LSE:ZIN
|
$1.41K |
|
Sab Events & Governance Now Media Limited
NSE:SABEVENTS
|
$1.41K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in CannTrust Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2017 to 2018, total equity changed from 70,868,418 to 174,025,794, a change of 103,157,376 (145.6%).
- Net loss of 13,553,616 reduced equity.
- New share issuances of 103,470,364 increased equity.
- Other comprehensive income increased equity by 14,473,784.
Equity Change Factors (2017 to 2018)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-13.55 Million | -7.79% |
| Share Issuances | $103.47 Million | +59.46% |
| Other Comprehensive Income | $14.47 Million | +8.32% |
| Other Changes | $-1.23 Million | -0.71% |
| Total Change | $- | 145.56% |
Book Value vs Market Value Analysis
This analysis compares CannTrust Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.00x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | $-0.08 | $0.00 | x |
| 2015-12-31 | $-0.11 | $0.00 | x |
| 2016-12-31 | $0.12 | $0.00 | x |
| 2017-12-31 | $0.88 | $0.00 | x |
| 2018-12-31 | $1.75 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently CannTrust Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -7.79%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -29.69%
- • Asset Turnover: 0.23x
- • Equity Multiplier: 1.16x
- Recent ROE (-7.79%) is above the historical average (-22.13%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 0.00% | 0.00% | 30287395.45x | 0.00x | $-11.22 Million |
| 2015 | 0.00% | -950.83% | 0.05x | 0.00x | $-4.85 Million |
| 2016 | -112.59% | -268.97% | 0.26x | 1.61x | $-12.83 Million |
| 2017 | 9.72% | 33.27% | 0.26x | 1.11x | $-201.41K |
| 2018 | -7.79% | -29.69% | 0.23x | 1.16x | $-30.96 Million |
Industry Comparison
This section compares CannTrust Holdings Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| CannTrust Holdings Inc (CNTTQ) | $190.18 Million | 0.00% | 0.18x | $1.41K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |